The economic impact of the problem is evident, with states accumulating 698 billion annually in direct costs , representing 7.7% of global healthcare spending (expected to reach 9.7% by 2035), not to mention the loss of productivity
GLP1-R: a novel pharmacological target for treating human bronchial hyperresponsiveness
A., Taweechaipaisankul, A., Kim, E
The choice for patients who are not candidates for medication or prefer not to use one
If you dont get the A1c control you need with just one of these agents alone, you can add on the other as well
doi: 10.3389/fimmu.2023.1156774 Received 01 February 2023 Accepted 26 June 2023 Published 11 July 2023 Volume 14 - 2023 Edited by Bowen Wu, Zhejiang University, China Reviewed by Xueping Li, Stanford University, United States